This article will be updated throughout the day, so check back often for more daily updates. The Vanguard S&P 500 ETF (NYSEMKT: VOO) is up 0.5% premarket on some surprisingly good economic news. The U ...

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

“OUR TAKE: 2026 will be another big year for the obesity market, with the launch of oral GLP-1s from LLY and NVO, better ...

We recently published 12 Stocks on Jim Cramer’s Radar. Pfizer Inc. (NYSE:PFE) is one of the stocks on Jim Cramer’s radar.

Athira Pharma has joined an attempt to rescue an asset abandoned by Pfizer. The biotech has secured near-global rights to a phase 3 breast cancer prospect in a deal with Sermonix Pharmaceuticals.

Pfizer Inc. is rated a Hold due to structural challenges despite recent 12% total return and compelling 6.7% dividend yield.

In a pivotal moment for investors, Pfizer (PFE) has reaffirmed its outlook for adjusted earnings per share for 2025, but has made noteworthy adjustments to its revenue projections. This article ...

Tilray Brands jumped 27.54% to close at $13.94, after trading between an intraday low of $10.50 and a high of $14.55; the ...

Today, Dec. 16, 2025, Pfizer's shrinking COVID cash flows could mean little growth next year as M&A bets will take time to deliver.

Dow Jones Top Company Headlines at 3 PM ET: Pepsi Worked to Keep Prices Higher at Retailers to Protect Walmart, FTC Found | Pfizer ... Pepsi Worked to Keep Prices Higher at Retailers to Protect ...

Pfizer Inc. forecast little to no sales growth next year as the drugmaker undertakes an effort to refresh its pipeline of hit drugs with a series of pricey acquisitions.

Adjusted Earnings Per Share: Pfizer has maintained its adjusted earnings per share outlook for 2025, indicating a steady operational performance. Revenue Forecast Revision: The downward adjustment in ...